News - Zaltrap, Financial

Filter

Current filters:

ZaltrapFinancial

Popular Filters

Regeneron posts strong growth for 2012, beating analysts' estimates

15-02-2013

US biotech firm Regeneron Pharmaceuticals (Nasdaq: REGN) yesterday announced that total revenues were…

BiotechnologyEyleaFinancialOncologyOphthalmicsRegeneronZaltrap

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top